Great Lakes NeuroTechnologies, a company using tablets and wearable sensors for Parkinson's diagnosis and therapy, will use a recent $1.5 million NIH grant to start a move toward direct-to-consumer marketability. This is the latest in a long series of NIH grants for the company since 2005 and brings the company's total grants to $14.2 million.
The system, called Kinesia HomeView, is currently...
It's one thing to detect the telltale stiffness, tremors, spasms and loss of muscle control of Parkinson's disease with wireless sensors, as Great Lakes Neurotechnologies is doing with its Kinesia HomeView system. It's another to add automatic medication administration to this type of technology.
A multi-country project funded by the European Union aims to do just that. Researchers in Spain,...
